User profiles for Philip Bejon
 | Philip BejonKEMRI-Wellcome Verified email at kemri-wellcome.org Cited by 21898 |
[HTML][HTML] Oral versus intravenous antibiotics for bone and joint infection
Background The management of complex orthopedic infections usually includes a prolonged
course of intravenous antibiotic agents. We investigated whether oral antibiotic therapy is …
course of intravenous antibiotic agents. We investigated whether oral antibiotic therapy is …
[HTML][HTML] Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age
Background Plasmodium falciparum malaria is a pressing global health problem. A previous
study of the malaria vaccine RTS,S (which targets the circumsporozoite protein), given with …
study of the malaria vaccine RTS,S (which targets the circumsporozoite protein), given with …
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Africa is
poorly described. The first case of SARS-CoV-2 in Kenya was reported on 12 March 2020, …
poorly described. The first case of SARS-CoV-2 in Kenya was reported on 12 March 2020, …
Phase 1 trials of rVSV Ebola vaccine in Africa and Europe
Background The replication-competent recombinant vesicular stomatitis virus (rVSV)–based
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …
Seven-year efficacy of RTS, S/AS01 malaria vaccine among young African children
Background The candidate malaria vaccine RTS,S/AS01 is being evaluated in order to
inform a decision regarding its inclusion in routine vaccination schedules. Methods We …
inform a decision regarding its inclusion in routine vaccination schedules. Methods We …
[PDF][PDF] Upregulation of TGF-β, FOXP3, and CD4+ CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection
Understanding the regulation of immune responses is central for control of autoimmune and
infectious disease. In murine models of autoimmunity and chronic inflammatory disease, …
infectious disease. In murine models of autoimmunity and chronic inflammatory disease, …
Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine
…, JJ Aponte, KP Asante, P Bejon… - … England Journal of …, 2015 - Mass Medical Soc
Background The RTS,S/AS01 vaccine targets the circumsporozoite protein of Plasmodium
falciparum and has partial protective efficacy against clinical and severe malaria disease in …
falciparum and has partial protective efficacy against clinical and severe malaria disease in …
Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure
Background The candidate malaria vaccine RTS,S/AS01E has entered phase 3 trials, but
data on long-term outcomes are limited. Methods For 4 years, we followed children who had …
data on long-term outcomes are limited. Methods For 4 years, we followed children who had …
Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised …
Background The RTS,S/AS01 malaria vaccine targets the circumsporozoite protein,
inducing antibodies associated with the prevention of Plasmodium falciparum infection. We …
inducing antibodies associated with the prevention of Plasmodium falciparum infection. We …
Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya
Background Infectious diseases often demonstrate heterogeneity of transmission among host
populations. This heterogeneity reduces the efficacy of control strategies, but also implies …
populations. This heterogeneity reduces the efficacy of control strategies, but also implies …
